<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/130"/><api:result><api:object category="publication" id="130" last-affected-when="2024-04-10T20:24:48.58+01:00" last-modified-when="2024-04-10T20:24:48.58+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/130" created-when="2010-05-17T13:46:11.767+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-03-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="4202467" source-id="28" source-name="eprints" source-display-name="White Rose Research Online" id-at-source="91892" last-modified-when="2022-12-28T20:31:45.53+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>In the UK there are standardized surveillance procedures for gestational trophoblastic disease. However, there are differences in practice between the two treatment centres in terms of definition of persistent gestational trophoblastic disease, prognostic risk assessment and chemotherapeutic regimens. The role of prophylactic chemotherapy for cerebral micrometastatic disease in persistent gestational trophoblastic disease is unclear. We have analysed the outcome of 69 patients with lung metastases who elsewhere might have received prophylactic intrathecal chemotherapy. Of the 69 patients, 67 received intravenous chemotherapy only. The other two patients had cerebral metastases at presentation. One patient who received only intravenous chemotherapy subsequently developed a cerebral metastasis, but this patient's initial treatment was compromised by non-compliance. This experience supports our current policy of not treating patients with pulmonary metastases, without clinical evidence of central nervous system (CNS) involvement, with prophylactic intrathecal therapy.</api:text></api:field><api:field name="acceptance-date" type="date" display-name="Date of acceptance"><api:date><api:day>27</api:day><api:month>7</api:month><api:year>1998</api:year></api:date></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Gillespie</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Siddiqui</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690203</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690203"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7-8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>CHORIOCARCINOMA</api:keyword><api:keyword>METHOTREXATE</api:keyword><api:keyword>CHEMOTHERAPY</api:keyword><api:keyword>METASTASES</api:keyword><api:keyword>THERAPY</api:keyword></api:keywords></api:field><api:field name="notes" type="text" display-name="Other information"><api:text>Â© 1999 Cancer Research Campaign. (Creative Commons Licence, Attribution-Non-Commercial-Share-Alike 3.0 http://creativecommons.org/licenses/by-nc-sa/3.0/.)</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1270</api:begin-page><api:end-page>1272</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="public-url" type="text" display-name="Public URL"><api:text>https://eprints.whiterose.ac.uk/id/eprint/91892</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Cancer Research UK </api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://www.doi.org/10.1038/sj.bjc.6690203</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>11</api:day><api:month>11</api:month><api:year>2015</api:year></api:date></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>3</api:day><api:month>8</api:month><api:year>2016</api:year></api:date></api:field><api:field name="repository-status" type="text" display-name="Availability"><api:text>Public</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>79</api:text></api:field><api:files><api:file proprietary-id="https://eprints.whiterose.ac.uk/id/file/766656"><api:filename>Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?.pdf</api:filename><api:file-url>https://eprints.whiterose.ac.uk/91892/6/Gestational trophoblastic disease%3A does central nervous system chemoprophylaxis have a role%3F.pdf</api:file-url><api:extension>pdf</api:extension><api:file-size>58620</api:file-size><api:mime-type>application/pdf</api:mime-type><api:checksum algorithm="md5">9ADE75F06E3B97BF243A2C7AB78640CC</api:checksum><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="1808542" source-id="1" source-name="manual" source-display-name="Manual" id-at-source="49647D96-5743-4E32-BBBA-58AEECE2CBC7" last-modified-when="2016-08-03T14:19:14.56+01:00"><api:verification-status>verified</api:verification-status><api:native><api:field name="acceptance-date" type="date" display-name="Date of acceptance"><api:date><api:day>27</api:day><api:month>7</api:month><api:year>1998</api:year></api:date></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Gillespie</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Siddiqui</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="c-goldoa" type="boolean" display-name="Gold Open Access?"><api:boolean>true</api:boolean></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690203</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690203"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7/8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1270</api:begin-page><api:end-page>1272</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher-licence" type="text" display-name="Publisher licence"><api:text>CC BY-NC-SA</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>3</api:day><api:month>8</api:month><api:year>2016</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>79</api:text></api:field></api:native></api:record><api:record format="native" id="1488332" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1038/sj.bjc.6690203" last-modified-when="2023-05-20T00:45:41.983+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Gillespie</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Siddiqui</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690203</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690203"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7-8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>12</api:day><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1270</api:begin-page><api:end-page>1272</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1038/sj.bjc.6690203</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>5</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>79</api:text></api:field></api:native></api:record><api:record format="native" id="3522734" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032983936" last-modified-when="2023-05-30T17:12:45.43+01:00"><api:citation-count>13</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>In the UK there are standardized surveillance procedures for gestational trophoblastic disease. However, there are differences in practice between the two treatment centres in terms of definition of persistent gestational trophoblastic disease, prognostic risk assessment and chemotherapeutic regimens. The role of prophylactic chemotherapy for cerebral micrometastatic disease in persistent gestational trophoblastic disease is unclear. We have analysed the outcome of 69 patients with lung metastases who elsewhere might have received prophylactic intrathecal chemotherapy. Of the 69 patients, 67 received intravenous chemotherapy only. The other two patients had cerebral metastases at presentation. One patient who received only intravenous chemotherapy subsequently developed a cerebral metastasis, but this patient's initial treatment was compromised by non-compliance. This experience supports our current policy of not treating patients with pulmonary metastases, without clinical evidence of central nervous system (CNS) involvement, with prophylactic intrathecal therapy.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Gillespie</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Cancer Res. Lab.</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35481567300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Siddiqui</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Southern General Hospital Glasgow</api:line><api:line type="city">Glasgow</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57212698680</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Cancer Res. Lab.</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7403206142</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Cancer Res. Lab.</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35109059400</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690203</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690203"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10098770</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7-8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1270</api:begin-page><api:end-page>1272</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>28</api:day><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gestational trophoblastic disease: Does central nervous system chemoprophylaxis have a role?</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>79</api:text></api:field></api:native></api:record><api:record format="native" id="130" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10098770" last-modified-when="2022-11-22T22:58:53.41+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>In the UK there are standardized surveillance procedures for gestational trophoblastic disease. However, there are differences in practice between the two treatment centres in terms of definition of persistent gestational trophoblastic disease, prognostic risk assessment and chemotherapeutic regimens. The role of prophylactic chemotherapy for cerebral micrometastatic disease in persistent gestational trophoblastic disease is unclear. We have analysed the outcome of 69 patients with lung metastases who elsewhere might have received prophylactic intrathecal chemotherapy. Of the 69 patients, 67 received intravenous chemotherapy only. The other two patients had cerebral metastases at presentation. One patient who received only intravenous chemotherapy subsequently developed a cerebral metastasis, but this patient's initial treatment was compromised by non-compliance. This experience supports our current policy of not treating patients with pulmonary metastases, without clinical evidence of central nervous system (CNS) involvement, with prophylactic intrathecal therapy.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Gillespie</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Gestational Trophoblastic Disease Screening and Treatment Centre, Yorkshire Cancer Research, Department of Clinical Oncology, Weston Park Hospital, Sheffield.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Siddiqui</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10098770</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690203</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690203"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC2362241</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7-8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Antidotes</api:keyword><api:keyword scheme="mesh">Antineoplastic Combined Chemotherapy Protocols</api:keyword><api:keyword scheme="mesh">Brain Neoplasms</api:keyword><api:keyword scheme="mesh">Dactinomycin</api:keyword><api:keyword scheme="mesh">Etoposide</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Follow-Up Studies</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Leucovorin</api:keyword><api:keyword scheme="mesh">Lung Neoplasms</api:keyword><api:keyword scheme="mesh">Methotrexate</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Patient Compliance</api:keyword><api:keyword scheme="mesh">Pregnancy</api:keyword><api:keyword scheme="mesh">Prognosis</api:keyword><api:keyword scheme="mesh">Retrospective Studies</api:keyword><api:keyword scheme="mesh">Risk Assessment</api:keyword><api:keyword scheme="mesh">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh">Uterine Neoplasms</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1270</api:begin-page><api:end-page>1272</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>6690203</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>13</api:day><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>79</api:text></api:field></api:native></api:record><api:record format="native" id="858397" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10098770" last-modified-when="2023-11-22T00:33:52.923+00:00"><api:citation-count>5</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>In the UK there are standardized surveillance procedures for gestational trophoblastic disease. However, there are differences in practice between the two treatment centres in terms of definition of persistent gestational trophoblastic disease, prognostic risk assessment and chemotherapeutic regimens. The role of prophylactic chemotherapy for cerebral micrometastatic disease in persistent gestational trophoblastic disease is unclear. We have analysed the outcome of 69 patients with lung metastases who elsewhere might have received prophylactic intrathecal chemotherapy. Of the 69 patients, 67 received intravenous chemotherapy only. The other two patients had cerebral metastases at presentation. One patient who received only intravenous chemotherapy subsequently developed a cerebral metastasis, but this patient's initial treatment was compromised by non-compliance. This experience supports our current policy of not treating patients with pulmonary metastases, without clinical evidence of central nervous system (CNS) involvement, with prophylactic intrathecal therapy.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Gestational Trophoblastic Disease Screening and Treatment Centre, Yorkshire Cancer Research, Department of Clinical Oncology, Weston Park Hospital, Sheffield.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Gillespie</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Siddiqui</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690203</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690203"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10098770</api:identifier><api:identifier scheme="pmc">PMC2362241</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7-8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British journal of cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh">Brain Neoplasms</api:keyword><api:keyword scheme="mesh">Lung Neoplasms</api:keyword><api:keyword scheme="mesh">Uterine Neoplasms</api:keyword><api:keyword scheme="mesh">Methotrexate</api:keyword><api:keyword scheme="mesh">Leucovorin</api:keyword><api:keyword scheme="mesh">Dactinomycin</api:keyword><api:keyword scheme="mesh">Etoposide</api:keyword><api:keyword scheme="mesh">Antineoplastic Combined Chemotherapy Protocols</api:keyword><api:keyword scheme="mesh">Antidotes</api:keyword><api:keyword scheme="mesh">Prognosis</api:keyword><api:keyword scheme="mesh">Risk Assessment</api:keyword><api:keyword scheme="mesh">Retrospective Studies</api:keyword><api:keyword scheme="mesh">Follow-Up Studies</api:keyword><api:keyword scheme="mesh">Patient Compliance</api:keyword><api:keyword scheme="mesh">Pregnancy</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Open Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1270</api:begin-page><api:end-page>1272</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher-licence" type="text" display-name="Publisher licence"><api:text>CC BY</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>research-article</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>79</api:text></api:field><api:files><api:file proprietary-id="https://www.nature.com/articles/6690203.pdf"><api:file-url>https://www.nature.com/articles/6690203.pdf</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file><api:file proprietary-id="https://europepmc.org/articles/PMC2362241?pdf=render"><api:file-url>https://europepmc.org/articles/PMC2362241?pdf=render</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="2903614" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1012763853" last-modified-when="2024-03-17T07:55:15.387+00:00"><api:citation-count>15</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Gillespie</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0614711555.42</api:identifier></api:identifiers></api:person><api:person><api:last-name>Siddiqui</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Southern General Hospital</api:line><api:line type="city">Glasgow</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01264302524.69</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.014331105607.96</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01257257663.76</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690203</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690203"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10098770</api:identifier><api:identifier scheme="pmc">PMC2362241</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7-8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc">Rare Diseases</api:keyword><api:keyword scheme="rcdc">Lung</api:keyword><api:keyword scheme="rcdc">Neurosciences</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="hrcs-rac">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac">4.2 Evaluation of markers and technologies</api:keyword><api:keyword scheme="hrcs-rac">4 Detection, screening and diagnosis</api:keyword><api:keyword scheme="hrcs-rac">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Antidotes</api:keyword><api:keyword scheme="mesh">Antineoplastic Combined Chemotherapy Protocols</api:keyword><api:keyword scheme="mesh">Brain Neoplasms</api:keyword><api:keyword scheme="mesh">Dactinomycin</api:keyword><api:keyword scheme="mesh">Etoposide</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Follow-Up Studies</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Leucovorin</api:keyword><api:keyword scheme="mesh">Lung Neoplasms</api:keyword><api:keyword scheme="mesh">Methotrexate</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Patient Compliance</api:keyword><api:keyword scheme="mesh">Pregnancy</api:keyword><api:keyword scheme="mesh">Prognosis</api:keyword><api:keyword scheme="mesh">Retrospective Studies</api:keyword><api:keyword scheme="mesh">Risk Assessment</api:keyword><api:keyword scheme="mesh">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh">Uterine Neoplasms</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>12</api:day><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Hybrid OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1270</api:begin-page><api:end-page>1272</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.22</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>79</api:text></api:field></api:native></api:record><api:record format="native" id="239815" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000078699500043" last-modified-when="2024-04-10T20:24:48.583+01:00"><api:citation-count>7</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Gillespie</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Siddiqui</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000078699500043&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690203</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690203"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">168NQ</api:identifier><api:identifier scheme="pubmed">10098770</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7-8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRITISH JOURNAL OF CANCER</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1270</api:begin-page><api:end-page>1272</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>79</api:text></api:field></api:native></api:record><api:record format="native" id="22334" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000078699500043" last-modified-when="2014-07-25T11:00:51.17+01:00"><api:citation-count>4</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Gillespie</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Siddiqui</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7-8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRIT J CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>CHORIOCARCINOMA</api:keyword><api:keyword>METHOTREXATE</api:keyword><api:keyword>CHEMOTHERAPY</api:keyword><api:keyword>METASTASES</api:keyword><api:keyword>THERAPY</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1270</api:begin-page><api:end-page>1272</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>79</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword origin="record-data" source="eprints">CHORIOCARCINOMA</api:keyword><api:keyword origin="record-data" source="eprints">METHOTREXATE</api:keyword><api:keyword origin="record-data" source="eprints">CHEMOTHERAPY</api:keyword><api:keyword origin="record-data" source="eprints">METASTASES</api:keyword><api:keyword origin="record-data" source="eprints">THERAPY</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antidotes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antineoplastic Combined Chemotherapy Protocols</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Brain Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Dactinomycin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Etoposide</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Follow-Up Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Leucovorin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Lung Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Methotrexate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Patient Compliance</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pregnancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Prognosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Retrospective Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Risk Assessment</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Uterine Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Brain Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Lung Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Uterine Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Methotrexate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Leucovorin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Dactinomycin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Etoposide</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antineoplastic Combined Chemotherapy Protocols</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antidotes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Prognosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Risk Assessment</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Retrospective Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Follow-Up Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Patient Compliance</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pregnancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Rare Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Lung</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Neurosciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">4.2 Evaluation of markers and technologies</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">4 Detection, screening and diagnosis</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antidotes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antineoplastic Combined Chemotherapy Protocols</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Brain Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Dactinomycin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Etoposide</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Follow-Up Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Leucovorin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Lung Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Methotrexate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Patient Compliance</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pregnancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Prognosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Retrospective Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Risk Assessment</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Uterine Neoplasms</api:keyword><api:keyword origin="record-data" source="wos">CHORIOCARCINOMA</api:keyword><api:keyword origin="record-data" source="wos">METHOTREXATE</api:keyword><api:keyword origin="record-data" source="wos">CHEMOTHERAPY</api:keyword><api:keyword origin="record-data" source="wos">METASTASES</api:keyword><api:keyword origin="record-data" source="wos">THERAPY</api:keyword><api:keyword scheme="for" origin="issn-inferred">1112 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for" origin="issn-inferred">1117 Public Health and Health Services</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Oncology &amp; Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3211 Oncology and carcinogenesis</api:keyword></api:keywords></api:all-labels><api:journal issn="0007-0920" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662" title="British Journal of Cancer"><api:records><api:record source-name="summary"><api:title>British Journal of Cancer</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/130/relationships"/></api:object></api:result></api:response>